Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

0.365
Delayed Data
As of Feb 05
 -0.0148 / -3.90%
Today’s Change
0.30
Today|||52-Week Range
2.13
-27.00%
Year-to-Date
No recent news for Cyclacel Pharmaceuticals Inc.

Today’s Trading

Previous close0.38
Today’s open0.36
Day’s range0.36 - 0.38
Volume33,143
Average volume (3 months)320,814
Market cap$12.7M
Dividend yield--
Data as of 3:53pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+30.47%
Earnings growth (this year)+51.69%
Earnings growth (next 5 years)--
Revenue growth (last year)+59.96%
P/E ratioNM
Price/Sales8.86
Price/Book0.39

Competitors

 Today’s
change
Today’s
% change
IMNPImmune Pharmaceutica...-0.01-2.33%
NEOTNeothetics Inc-0.01-1.04%
CDXICardax Inc-0.03-14.57%
ONTXOnconova Therapeutic...+0.02+3.77%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 22, 2016
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$1.7M
Annual profit (last year)-$19.4M
Net profit margin-1,119.15%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Spiro Rombotis
COO, CFO, Secretary, Director &
Executive VP
Paul McBarron
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts

Partner Offers